celularity.com
Open in
urlscan Pro
141.193.213.11
Public Scan
Submitted URL: http://celularity.com/
Effective URL: https://celularity.com/
Submission: On January 31 via manual from PH — Scanned from DE
Effective URL: https://celularity.com/
Submission: On January 31 via manual from PH — Scanned from DE
Form analysis 1 forms found in the DOM
GET https://celularity.com/
<form role="search" method="get" id="wtbx_search_form" class="clearfix" action="https://celularity.com/">
<div class="wtbx-col-lg-7 wtbx-col-md-7 wtbx-col-sm-6">
<div class="wtbx_search_field_wrapper wtbx_search_input_wrapper">
<i class="scape-ui-search wtbx-click"></i>
<input type="text" name="s" tabindex="1" class="wtbx_search_field wtbx_search_input" placeholder="Search">
</div>
</div>
<div class="wtbx-col-lg-1 wtbx-col-md-1 wtbx-col-sm-1 wtbx-col-xs-2"><span class="wtbx_search_in">in</span></div>
<div class="wtbx-col-lg-4 wtbx-col-md-4 wtbx-col-sm-5 wtbx-col-xs-10">
<div class="wtbx_search_field_wrapper wtbx_search_select_wrapper">
<select tabindex="2" class="wtbx_search_field wtbx_for_custom_dropdown" name="post_type">
<option value="any">Everywhere</option>
<option value="attachment">Media</option>
<option value="page">Pages</option>
<option value="portfolio">Portfolio</option>
<option value="post">Posts</option>
</select>
<div class="wtbx_search_field wtbx_search_select wtbx_with_custom_dropdown wtbx-click">Everywhere</div>
</div>
</div>
<div class="wtbx-col-sm-12">
<input type="submit" tabindex="3" value="Search" class="wtbx-button wtbx-button-primary button-lg button-fw">
</div>
</form>Text Content
* Home
* Company
* Column 1
* Company
* About Us
* Collaborations
* Lifebank
* Manufacturing
* Column 2
* Meet The Team
* Leadership
* Board of Directors
* Scientific Advisors
* Careers
* Tour Our Facility
* Newsroom
* Pipeline
* The Pipeline
* Placenta
* NK Cell Platform
* T Cell Platform
* Exosomes
* Expanded Access Policy
* Investors
* Investor Relations
* Press Releases
* Stock Information
* Investor FAQs
* Corporate Governance
* SEC Filings
* Home
* Company
* Column 1
* Company
* About Us
* Collaborations
* Lifebank
* Manufacturing
* Column 2
* Meet The Team
* Leadership
* Board of Directors
* Scientific Advisors
* Careers
* Tour Our Facility
* Newsroom
* Pipeline
* The Pipeline
* Placenta
* NK Cell Platform
* T Cell Platform
* Exosomes
* Expanded Access Policy
* Investors
* Investor Relations
* Press Releases
* Stock Information
* Investor FAQs
* Corporate Governance
* SEC Filings
*
*
*
*
*
MENU
THE NEXT
EVOLUTION IN
CELLULAR
MEDICINE
Celularity is a clinical-stage biotechnology company developing off-the-shelf
placental-derived allogeneic cell therapies including genetically modified and
unmodified NK cells, engineered T cells including CAR-T cells, and
mesenchymal-like adherent stromal cells (ASCs), targeting indications across
cancer, immunologic, infectious, and degenerative diseases.
COMPANY PIPELINE
BEST IN CLASS & SCALABLE
Cellular Medicine manufacturing
Featuring industry leading and diverse product lines
ALLOGENEIC PLATFORM
Built on two decades of science
Driven by a deep, seasoned management team
INNOVATIVE PLACENTA-DERIVED
T cells, NK Cells, and pluripotent stem cells
With greater expandability, persistence, and stem-ness
OUR MISSION
IS TO LEAD THE NEXT EVOLUTION IN CELLULAR MEDICINE BY DELIVERING OFF-THE-SHELF
ALLOGENEIC CELLULAR THERAPIES, AT UNPARALLELED SCALE, QUALITY, AND ECONOMICS
OUR VISION
HARNESS THE UNIQUE BIOLOGY & READY AVAILABILITY OF THE PLACENTA
* Unmet Global Need
Significant unmet global need for allogeneic cellular medicines delivered
on-demand, off-the-shelf
* Groundbreaking Research
Groundbreaking basic & translational research into the unique biological
activity of placental-derived cells
* Pioneering Technology
Pioneering technology platform of placental-derived cellular medicines and
advanced biomaterials
* Industry Timing
The time has arrived for cellular medicines that overcome barriers of scale,
quality, and economics
Celularity ishyper innovative|
COMPANY PIPELINE
Cellular Medicine Manufacturing
THE PROCESS IS THE PRODUCT
A fully integrated, purpose-built manufacturing, translational research and
biobanking center
* Purpose built facility staffed by over 100 highly specialized scientists,
engineers & technicians
* 150,000sq ft including laboratory and advanced manufacturing space for
cellular medicine & biomaterials
* Clinical Scale – (9) Grade C/ISO 7 suites and (6) Grade D/ISO 8 labs ALL
GMP-CAPABLE
Tour Our Facility
The Latest From Our
NEWSROOM
CELULARITY COMPLETES STRATEGIC REVIEW OF 2023 INITIATIVES, INCLUDING ANTICIPATED
BIOMATERIALS PRODUCTION RAMP-UP AND PIPELINE PRIORITIZATION OF NEXT-GENERATION
PRODUCT CANDIDATES
Celularity Inc
CELULARITY AND CH TRADING GROUP ANNOUNCE PRODUCT DISTRIBUTION AGREEMENT WITH
TAMER GROUP TO BE THE EXCLUSIVE DISTRIBUTOR FOR THE KINGDOM OF SAUDI ARABIA
Celularity Inc
CELULARITY AND CH TRADING GROUP ANNOUNCE TERRITORY DISTRIBUTION AGREEMENT FOR
THE MIDDLE EAST
Celularity Inc
CELULARITY’S PLACENTAL-DERIVED ALLOGENEIC CELL THERAPY PROVIDES CLINICALLY
MEANINGFUL BENEFIT AND DURABLE BIOLOGICAL EFFECT IN PATIENTS WITH MODERATE TO
SEVERE CROHN’S DISEASE IN PHASE 1, PHASE 1B/2A AND PHASE 1B STUDIES
Celularity Inc.
Celularity Inc. expansion is driven by experienced Cellular Medicine leaders &
innovators with deep expertise in clinical development & regulatory approval.
Meet Our Board of Directors
(908) 768 - 2170
Celularity Inc.
170 Park Ave
Florham Park, NJ 07932
*
*
*
*
*
Company
* Pipeline
* Our Story
* Leadership
* Scientific Advisors
* Board of Directors
* Careers
Science
* Placenta
* NK Cell Platform
* T Cell Platform
* Manufacturing
* Lifebank
* Biovance
Investors
* Investor Relations
* Investor Newsroom
* Stock Information
* Corporate Governance
* SEC Filings
* Investor FAQs
Celularity Inc. © 2022. All rights reserved. NASDAQ:CELU
Privacy Policy Terms & Conditions
in
EverywhereMediaPagesPortfolioPosts
Everywhere
F.A.Q
Support Forum
Video Tutorials
Search panel can contain any widgets and shortcodes.
Call us: (908) 768 – 2170
*
*
*